Invesco Ltd. Decreases Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Invesco Ltd. reduced its stake in Henry Schein by 0.4%, now holding approximately 4.06% of the company, valued at $338.6 million.
• Multiple institutional investors made significant adjustments to their positions, with Whittier Trust Co. increasing its holdings by 714.3% in the first quarter.
• Henry Schein's recent quarterly earnings report revealed an EPS of $1.10, missing the consensus estimate of $1.19, while revenue grew by 3.3% year-over-year.

Invesco Ltd. lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 0.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,944,393 shares of the company's stock after selling 19,016 shares during the period. Invesco Ltd. owned about 4.06% of Henry Schein worth $338,641,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Farther Finance Advisors LLC lifted its holdings in shares of Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock valued at $186,000 after purchasing an additional 1,898 shares during the last quarter. State of Alaska Department of Revenue boosted its holdings in Henry Schein by 2.8% in the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock valued at $1,000,000 after purchasing an additional 395 shares during the period. Oppenheimer Asset Management Inc. increased its position in shares of Henry Schein by 5.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after buying an additional 678 shares during the period. GAMMA Investing LLC increased its holdings in Henry Schein by 37.8% during the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock valued at $270,000 after buying an additional 1,081 shares during the last quarter. Finally, Wellington Management Group LLP grew its holdings in Henry Schein by 12.6% during the 4th quarter. Wellington Management Group LLP now owns 6,902 shares of the company's stock valued at $478,000 after purchasing an additional 775 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Performance

Shares of Henry Schein stock traded down $0.08 on Friday, reaching $67.83. 1,009,619 shares of the stock were exchanged, compared to its average volume of 1,772,125. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The business has a 50 day moving average price of $70.86 and a two-hundred day moving average price of $70.90. The firm has a market capitalization of $8.23 billion, a price-to-earnings ratio of 21.86, a PEG ratio of 2.28 and a beta of 0.81. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The company had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same quarter in the previous year, the company posted $1.23 earnings per share. The firm's revenue for the quarter was up 3.3% compared to the same quarter last year. Analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Wells Fargo & Company cut their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Evercore ISI decreased their price target on Henry Schein from $78.00 to $70.00 and set an "in-line" rating for the company in a research report on Wednesday, August 6th. Barrington Research decreased their price target on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a report on Wednesday, August 6th. Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Finally, Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Nine equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $75.58.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.